New York Times: Stem cell research is oversold
An article in the New York Times explains the risky business of scientific research, where “there are far fewer hits than misses” when it comes to research grants ever paying off. One of the biggest offenders? Embryonic stem cell research. Stem cell researchers have created an illusion of progress by claiming regular advances in the 12 years … Read more